Virginia Commonwealth University

VCU Massey Cancer Center

Targeted treatment Herceptin found to greatly improve long-term survival of HER2-positive breast cancer patients

Charles Geyer, M.D., F.A.C.P.

VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute (NCI)-supported clinical trials which demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.  The combined study was designed to determine the long-term safety and efficacy of the drug trastuzumab, which is commonly known as Herceptin and is primarily used alongside chemotherapy to treat HER2-positive breast cancer. The study focused on both the overall survival rates of patients up to ten years post-treatment as well as the known and potentially harmful side effects to the cardiac system.

Continue reading →

Scientists define important gene interaction that drives aggressive brain cancer

Paul B. Fisher, M.Ph., Ph.D., and Luni Emdad, M.B.B.S., Ph.D.

Scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma. 

Continue reading →

Massey physicians win Best Bedside Manner Awards

VCU Massey Cancer Center physicians were recognized by the community as having the best bedside manner in the 2014 Annual Best Bedside Manner Awards presented by Our Health Richmond magazine. The public voted for medical providers in the Richmond area based on kindness, empathy and attentiveness.

Continue reading →

Massey scientists seek to improve stem cell transplant outcomes through computer modeling of next generation sequencing data

Scientists at VCU Massey Cancer Center’s award-winning Bone Marrow Transplant (BMT) Program recently published several studies that support the possibility of using next-generation DNA sequencing and mathematical modeling to not only understand the variability observed in clinical outcomes of stem cell transplantation, but also to provide a theoretical framework to make transplantation a possibility for more patients who do not have a related donor.  

Continue reading →

The Cancer Research and Resource Center of Southern Virginia in Danville moves to new location

The Cancer Research and Resource Center of Southern Virginia in Danville has moved to a new location that is more accessible to cancer patients, survivors and their families and caregivers. After four years at the Institute for Advanced Learning and Research, the office now resides in Danville’s Main Street community at Kennedy Hall, 103 S. Main Street, formerly part of Stratford College.

Continue reading →